$OPXA News Opexa, BreitBurn, Hudson Pacific pric
Post# of 72711
Posted On: 01/15/2014 1:37:00 PM
$OPXA News
Opexa, BreitBurn, Hudson Pacific price offerings 12:07 p.m. Feb. 7, 2013 - MarketWatch.com
Opexa Therapeutics grants drug license to Merck 9:38 a.m. Feb. 5, 2013 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 4:27 p.m. Jan. 5, 2011 - MarketWatch
Glaxo, Opexa in drug sector spotlight 12:15 p.m. Jan. 5, 2011 - Val Brickates Kennedy
Opexa soars on talks with FDA over MS drug 10:56 a.m. Jan. 5, 2011 - William Spain
Avanir, Opexa gain ahead of presentations 2:16 p.m. April 6, 2010 - Val Brickates Kennedy
US Stock Futures Up; Fed Decision In Focus 5:49 a.m. Dec. 18, 2013 - benzinga.com
Opexa Therapeutics Prices 4.12M Share Offering at/$1.70/Share 4:58 a.m. Dec. 18, 2013 - benzinga.com
Opexa Converts all Convertible Secured Promissory Notes into Common Stock 4:32 a.m. Sept. 25, 2013 - benzinga.com
Weekly CFO Buys Highlight 11:32 a.m. Aug. 19, 2013 - GuruFocus.com
9 Compelling Reasons To Buy Opexa Therapeutics Right Now 11:44 a.m. Aug. 15, 2013 - Seeking Alpha
The Highs And The Lows: Opexa's Changing Market Trends 1:49 p.m. Aug. 12, 2013 - Seeking Alpha
Closing Bell for Thursday on Wall Street: Markets Open Lower, Close with Gains 2:30 p.m. Aug. 8, 2013 - 247WallSt.com
Opexa Morphs from Mystery Mega-Rally to Money Killer 8:56 a.m. Aug. 8, 2013 - 247WallSt.com
Opexa Therapeutics Prices 12M Share Offering at $1.50/Share 8:06 p.m. Aug. 7, 2013 - benzinga.com
Closing Bell for Wednesday on Wall Street: Markets Lower at Open, Lower at Close 2:36 p.m. Aug. 7, 2013 - 247WallSt.com
Morning Market Losers 8:09 a.m. May 14, 2013 - benzinga.com
Biotech Movers: Optimer Rockets, Ziopharm in Free Fall 2:25 a.m. April 8, 2013 - InvestorPlace.com
10-K: OPEXA THERAPEUTICS, INC. 8:16 a.m. March 29, 2013 - Edgar Online - (EDG = 10Q, 10K)
Chelsea Therapeutics: A Shoe-In For FDA Approval, Shares Could Double From Here 8:02 p.m. March 26, 2013 - Seeking Alpha
Market Close: Big Winners & Losers for March 26, 2013 (LEDS, BVX, PTEK, OPXA, LOGM, ZIOP, STXS, GMAN, GMXR, PRTS) 2:35 p.m. March 26, 2013 - 247WallSt.com
Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors 8:01 a.m. March 26, 2013 - Seeking Alpha
Opexa Therapeutics Poised For Breakout 9:39 a.m. March 12, 2013 - Seeking Alpha
Market Close: Today’s Big Winners & Losers (OSIR, END, APP, HCI, PTEK, RDIB, MELA, OPXA, ACUR, RWC) 3:56 p.m. March 6, 2013 - 247WallSt.com
Opexa Therapeutics Gets Attention From Institutions, Should It Get Yours? 2:22 p.m. Feb. 14, 2013 - Seeking Alpha
Biotech Movers: A Doubler for Opexa 2:30 a.m. Feb. 11, 2013 - InvestorPlace.com
Opexa Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 10:18 a.m. Dec. 23, 2013 - BusinessWire
Opexa Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock 9:15 p.m. Dec. 17, 2013 - BusinessWire
Opexa Therapeutics, Inc. Announces Proposed Public Offering of Common Stock 4:33 p.m. Dec. 17, 2013 - BusinessWire
Opexa Therapeutics Provides MS Trial Enrollment Update; 70% of Patients Enrolled 8:00 a.m. Dec. 16, 2013 - BusinessWire
New Supply Agreements and Analytical Tools, Expansions, Conference Presentations and Financial Results - Research Report on WuXi PharmaTech, Sirona, ICON, Opexa Therapeutic and Karyopharm Therapeutics 9:04 a.m. Nov. 20, 2013 - PR Newswire
Opexa Therapeutics Selected as a "Top 10 Advanced Therapy Projects to Watch" 9:00 a.m. Nov. 12, 2013 - BusinessWire
Opexa CEO Invited to Join Personalized Medicine Panel at New York CEO Conference 9:00 a.m. Nov. 8, 2013 - BusinessWire
Opexa Therapeutics Reports Third Quarter 2013 Financial Results and Provides Corporate Update 4:05 p.m. Nov. 7, 2013 - BusinessWire
CORRECTING and REPLACING Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Third Quarter 2013 Financial Results 9:51 a.m. Nov. 6, 2013 - BusinessWire
Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Third Quarter 2013 Financial Results 9:00 a.m. Nov. 6, 2013 - BusinessWire
Opexa Therapeutics Supports National Multiple Sclerosis Society as a Corporate Sponsor of Walk MS 8:00 a.m. Oct. 23, 2013 - BusinessWire
Opexa Therapeutics Immune Monitoring Program Featured in Neurology Reviews 8:00 a.m. Oct. 21, 2013 - BusinessWire
Founder of St. Jude Medical to Keynote RedChip Emerging Growth Showcase on Oct. 23-24 12:01 p.m. Oct. 18, 2013 - GlobeNewswire
The RedChip Money Report TV Show Now Airing Weekly on Bloomberg Europe: 139 Million Homes 10:30 a.m. Oct. 17, 2013 - GlobeNewswire
Opexa Therapeutics CEO to Appear on The RedChip Money Report on Fox Business News 8:00 a.m. Oct. 17, 2013 - BusinessWire
Exclusive Video Interviews With CEOs Now on Equities.com: CGIX, CYTR, GWPH, HTBX, OPXA 7:01 a.m. Oct. 9, 2013 - GlobeNewswire
Faruqi & Faruqi, LLP Launches An Investigation Against Opexa Therapeutics, Inc. (OPXA) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors 4:15 p.m. Oct. 8, 2013 - BusinessWire
Opexa Therapeutics' CEO Featured in Leading Life Science Publication 8:00 a.m. Oct. 7, 2013 - BusinessWire
Opexa Therapeutics' Therapy for Multiple Sclerosis Featured in FOX Television News Story 8:00 a.m. Oct. 2, 2013 - BusinessWire
Opexa CEO Invited Panelist at 9th Annual Burrill Personalized Medicine Meeting 8:00 a.m. Sept. 30, 2013 - BusinessWire
Opexa, BreitBurn, Hudson Pacific price offerings 12:07 p.m. Feb. 7, 2013 - MarketWatch.com
Opexa Therapeutics grants drug license to Merck 9:38 a.m. Feb. 5, 2013 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 4:27 p.m. Jan. 5, 2011 - MarketWatch
Glaxo, Opexa in drug sector spotlight 12:15 p.m. Jan. 5, 2011 - Val Brickates Kennedy
Opexa soars on talks with FDA over MS drug 10:56 a.m. Jan. 5, 2011 - William Spain
Avanir, Opexa gain ahead of presentations 2:16 p.m. April 6, 2010 - Val Brickates Kennedy
US Stock Futures Up; Fed Decision In Focus 5:49 a.m. Dec. 18, 2013 - benzinga.com
Opexa Therapeutics Prices 4.12M Share Offering at/$1.70/Share 4:58 a.m. Dec. 18, 2013 - benzinga.com
Opexa Converts all Convertible Secured Promissory Notes into Common Stock 4:32 a.m. Sept. 25, 2013 - benzinga.com
Weekly CFO Buys Highlight 11:32 a.m. Aug. 19, 2013 - GuruFocus.com
9 Compelling Reasons To Buy Opexa Therapeutics Right Now 11:44 a.m. Aug. 15, 2013 - Seeking Alpha
The Highs And The Lows: Opexa's Changing Market Trends 1:49 p.m. Aug. 12, 2013 - Seeking Alpha
Closing Bell for Thursday on Wall Street: Markets Open Lower, Close with Gains 2:30 p.m. Aug. 8, 2013 - 247WallSt.com
Opexa Morphs from Mystery Mega-Rally to Money Killer 8:56 a.m. Aug. 8, 2013 - 247WallSt.com
Opexa Therapeutics Prices 12M Share Offering at $1.50/Share 8:06 p.m. Aug. 7, 2013 - benzinga.com
Closing Bell for Wednesday on Wall Street: Markets Lower at Open, Lower at Close 2:36 p.m. Aug. 7, 2013 - 247WallSt.com
Morning Market Losers 8:09 a.m. May 14, 2013 - benzinga.com
Biotech Movers: Optimer Rockets, Ziopharm in Free Fall 2:25 a.m. April 8, 2013 - InvestorPlace.com
10-K: OPEXA THERAPEUTICS, INC. 8:16 a.m. March 29, 2013 - Edgar Online - (EDG = 10Q, 10K)
Chelsea Therapeutics: A Shoe-In For FDA Approval, Shares Could Double From Here 8:02 p.m. March 26, 2013 - Seeking Alpha
Market Close: Big Winners & Losers for March 26, 2013 (LEDS, BVX, PTEK, OPXA, LOGM, ZIOP, STXS, GMAN, GMXR, PRTS) 2:35 p.m. March 26, 2013 - 247WallSt.com
Opexa: A Significant Growth Opportunity For Short-Term Traders And Long-Term Investors 8:01 a.m. March 26, 2013 - Seeking Alpha
Opexa Therapeutics Poised For Breakout 9:39 a.m. March 12, 2013 - Seeking Alpha
Market Close: Today’s Big Winners & Losers (OSIR, END, APP, HCI, PTEK, RDIB, MELA, OPXA, ACUR, RWC) 3:56 p.m. March 6, 2013 - 247WallSt.com
Opexa Therapeutics Gets Attention From Institutions, Should It Get Yours? 2:22 p.m. Feb. 14, 2013 - Seeking Alpha
Biotech Movers: A Doubler for Opexa 2:30 a.m. Feb. 11, 2013 - InvestorPlace.com
Opexa Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares 10:18 a.m. Dec. 23, 2013 - BusinessWire
Opexa Therapeutics, Inc. Announces Pricing of Public Offering of Common Stock 9:15 p.m. Dec. 17, 2013 - BusinessWire
Opexa Therapeutics, Inc. Announces Proposed Public Offering of Common Stock 4:33 p.m. Dec. 17, 2013 - BusinessWire
Opexa Therapeutics Provides MS Trial Enrollment Update; 70% of Patients Enrolled 8:00 a.m. Dec. 16, 2013 - BusinessWire
New Supply Agreements and Analytical Tools, Expansions, Conference Presentations and Financial Results - Research Report on WuXi PharmaTech, Sirona, ICON, Opexa Therapeutic and Karyopharm Therapeutics 9:04 a.m. Nov. 20, 2013 - PR Newswire
Opexa Therapeutics Selected as a "Top 10 Advanced Therapy Projects to Watch" 9:00 a.m. Nov. 12, 2013 - BusinessWire
Opexa CEO Invited to Join Personalized Medicine Panel at New York CEO Conference 9:00 a.m. Nov. 8, 2013 - BusinessWire
Opexa Therapeutics Reports Third Quarter 2013 Financial Results and Provides Corporate Update 4:05 p.m. Nov. 7, 2013 - BusinessWire
CORRECTING and REPLACING Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Third Quarter 2013 Financial Results 9:51 a.m. Nov. 6, 2013 - BusinessWire
Opexa Therapeutics Announces News Release and Conference Call Schedule to Discuss Third Quarter 2013 Financial Results 9:00 a.m. Nov. 6, 2013 - BusinessWire
Opexa Therapeutics Supports National Multiple Sclerosis Society as a Corporate Sponsor of Walk MS 8:00 a.m. Oct. 23, 2013 - BusinessWire
Opexa Therapeutics Immune Monitoring Program Featured in Neurology Reviews 8:00 a.m. Oct. 21, 2013 - BusinessWire
Founder of St. Jude Medical to Keynote RedChip Emerging Growth Showcase on Oct. 23-24 12:01 p.m. Oct. 18, 2013 - GlobeNewswire
The RedChip Money Report TV Show Now Airing Weekly on Bloomberg Europe: 139 Million Homes 10:30 a.m. Oct. 17, 2013 - GlobeNewswire
Opexa Therapeutics CEO to Appear on The RedChip Money Report on Fox Business News 8:00 a.m. Oct. 17, 2013 - BusinessWire
Exclusive Video Interviews With CEOs Now on Equities.com: CGIX, CYTR, GWPH, HTBX, OPXA 7:01 a.m. Oct. 9, 2013 - GlobeNewswire
Faruqi & Faruqi, LLP Launches An Investigation Against Opexa Therapeutics, Inc. (OPXA) For Potential Breaches Of Fiduciary Duties By Its Board Of Directors 4:15 p.m. Oct. 8, 2013 - BusinessWire
Opexa Therapeutics' CEO Featured in Leading Life Science Publication 8:00 a.m. Oct. 7, 2013 - BusinessWire
Opexa Therapeutics' Therapy for Multiple Sclerosis Featured in FOX Television News Story 8:00 a.m. Oct. 2, 2013 - BusinessWire
Opexa CEO Invited Panelist at 9th Annual Burrill Personalized Medicine Meeting 8:00 a.m. Sept. 30, 2013 - BusinessWire
(0)
(0)Scroll down for more posts ▼